Breast tumor developed in a pregnant rat after treatment with the teratogen Cycloheximide

Hippokratia

Volumn 14, Issue 2, 2010, Pages 136-138

  Emmanouil Nikoloussi, E N ^a   Nikoloussis, E ^a   Manthou, M E ^a   Goula, O C H ^a   Likartsis, C ^a   Papamitsou, T ^a   Frangou, H ^a   Massouridou, S ^a   Lazaridis, C ^a   Manthos, A ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Breast tumor; Cycloheximide; Estrogen receptors; Teratogenesis; Toxicity

Indexed keywords

CYCLOHEXIMIDE; EOSIN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; HEMATOXYLIN; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CARCINOGENICITY; CONTROLLED STUDY; EMBRYO; EMBRYOTOXICITY; FEMALE; GESTATION PERIOD; HISTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; NONHUMAN; PREGNANCY; RAT; TERATOGENICITY; TUMOR GROWTH; TUMOR VOLUME;

EID: 77950833507     PISSN: 11084189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Philips HL, Clarkson MJ. Spontaneous change from overt to covert infection of Chlamydia pecorum in cycloheximide-treated mouse McCoy cells. Infect Immun. 1995; 63: 3729-3730.
2. Clotworthy M, Traynor D. On the effects of cycloheximide on cell motility and polarisation in Dictyostelium discoideum. MBMC Cell Biology. 2006; 24: 7-5.
3. Katyare SS, Fatterparker P, Sreenivasan A. Study of protein synthesis in rat liver mitochondria use of cycloheximide. Eur J Biochem. 1977; 73: 287-296.
4. Agrawal R, Pelkonen J, Mdontyjdrvi RA. Effect of Gamma-lnterferon or Cycloheximide Treatment on Viral and c-myc Transcripts in Bovine-Papillomavirus-Type-1-Transformed Primary Mouse Fibroblasts. Intervirology. 1993; 36: 44-52
5. Mullauer L, Mosberger I, Grusch M, Rudas M, Chott A. Fas ligand is expressed in normal breast epithelial cells and is frequently up-regulated in breast cancer. Pathol. 2000; 190: 20-30. Comment in: J Pathol. 2000; 191: 468-470.
6. Sommer S, Fuqua SA. Estrogen receptor and breast cancer. Semin Cancer Biol. 2001; 11: 339-352.
7. Skliris GP, Lewis A, Emberley E, Peng B, Weebadda WK, Kemp A, et al. Estrogen receptor-beta regulates psoriasin (S100A7) in human breast cancer. Breast Cancer Res Treat. 2007; 104: 75-85. Epub 2006 Sep 29.
8. Harris M, Zacharewski T, Safe S. Effects of 2,3,7,8-tetrachlo-rodibenzo-p-dioxin and related compounds on the occupied nuclear estrogen receptor in MCF-7 human breast cancer cells. Cancer Res. 1990; 50: 3579-3584.
9. Swami S, Krishnan AV, Feldman D. 1-alpha,25-Dihydroxy vitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells. Clin Cancer Res. 2000; 6: 3371-3379.
10. Zhang X, Christenson LK, Nothnick WB. Regulation of MMP-9 expression and activity in the mouse uterus by estrogen. Mol Reprod Dev. 2007; 74: 321-331.
11. Choi E.M. Apigenin increases osteoblastic differentiation and inhibits tumor necrosis factor-alpha-induced production of interleukin-6 and nitric oxide in osteoblastic MC3T3-E1 cells. Pharmazie. 2007; 62: 216-220.
12. Ruohola JK, Valve EM, Karkkainen MJ, Joukov V, Alitalo K, Harkonen PL. Vascular endothelial growth factors are differentially regulated by steroid hormones and antiestrogens in breast cancer cells. Mol Cell Endocrinol. 1999; 149: 29-40